Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vlachakis, N. D.
Right arrow Articles by Mendlowitz, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Vlachakis, N. D.
Right arrow Articles by Mendlowitz, M.
(Chest. 1977;71:38-43.)
© 1977 American College of Chest Physicians

Blood Pressure Responses to Catecholamines during Beta-Adrenergic Blockade with Propranolol in Hypertensive Subjects

Nicholas D. Vlachakis M.D.1; Daisy DeGuia M.D.1; and Milton Mendlowitz M.D., F.C.C.P.1

1 From the Hypertension Division, Department of Medicine, Mount Sinai School of Medicine, City University of New York, New York

In 14 patients with essential hypertension, the responses of the heart rate and blood pressure to infusion of norepinephrine and epinephrine separately while off (control period) or on therapy with β-adrenergic receptor blockade was examined. By titrating dosage against the response of blood pressure and pulse rate, propranolol hydrochloride was administered orally at 160 mg/day in four divided doses. There was a significant decrease in systolic blood pressure and in pulse rate during propranolol therapy, whereas diastolic blood pressure decreased but not significantly so. Normal blood pressure (140/90 mm Hg or less) was attained only in five patients. The infusion of epinephrine and then norepinephrine produced a significant increase in both systolic and diastolic blood pressure during propranolol therapy, but the magnitude of the rise was significantly greater than that attained in the control period only during epinephrine infusion. We conclude that the transient hypertensive episodes which have been observed during office visits in some hypertensive patients treated with propranolol are due mainly to release of epinephrine.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1977 by the American College of Chest Physicians.